We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Regulates Insulin to Extend Lifespan

By Biotechdaily staff writers
Posted on 05 Sep 2005
Scientists have found a protein that has demonstrated the ability to extend life in laboratory mice by regulating insulin. More...
The protein, called Klotho, is found in various species. In mice, it performs like a hormone circulating through the bloodstream and attaches to cells.

Treatments based on this hormone may provide a means to extend the life span of living organisms or lessen the effects of aging, according to Dr. Makoto Kuro-o, assistant professor of pathology at the University of Texas Southwestern Medical Center (Dallas, TX, USA) and senior author of the study, which was published in the August 25, 2005, online edition of the journal Science. "It could be one of the significant steps for developing anti-aging therapy,” noted Dr. Kuro-o.

Dr. Kuro-o and coworkers initially discovered the Klotho gene in 1997, naming it after one of the mythical Greek fates who controlled the length of human life. Their earlier studies demonstrated that mutant mice lacking the Klotho gene appear healthy until approximately three to four weeks old, when they begin to show signs of aging, developing osteoporosis, skin atrophy, arteriosclerosis, and emphysema. The mice died prematurely at about two months.

For the current study, the investigators created a second strain of mutant mice in which the Klotho gene produced more of the protein than in normal mice. Those mice lived between 19-31% longer than normal mice. The scientists were particularly interested in how the hormone affected insulin, because making an animal resistant to insulin increases its lifespan--a phenomenon found in animals ranging from worms to mice.

The mice with higher levels of Klotho had more insulin in their system than the healthy mice, indicating that the Klotho mice were resistant to insulin; they had to generate it to make up for the resistance. The contrary was true with the mice lacking Klotho. They were more sensitive to insulin and had decreased levels of it.

The influence on insulin creates an obstacle for Klotho should it be used as an anti-aging therapy. It may lengthen life spans, but it could also make an animal diabetic. Mice with the excessive Klotho also had less offspring than normal mice, according to Dr. Kuro-o.




Related Links:
University of Texas Southwestern Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Hematology Consumables
Bioblood Devices
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.